ID   BPNT1_HUMAN             Reviewed;         308 AA.
AC   O95861; A8K7C8; B4DPS5; B4DUS9; D3DTA9; Q8WVL5; Q9UGJ3;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   22-JUL-2015, entry version 127.
DE   RecName: Full=3'(2'),5'-bisphosphate nucleotidase 1;
DE            EC=3.1.3.7;
DE   AltName: Full=Bisphosphate 3'-nucleotidase 1;
DE   AltName: Full=PAP-inositol 1,4-phosphatase;
DE            Short=PIP;
GN   Name=BPNT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=10224133; DOI=10.1074/jbc.274.19.13619;
RA   Spiegelberg B.D., Xiong J.-P., Smith J.J., Gu R.F., York J.D.;
RT   "Cloning and characterization of a mammalian lithium-sensitive
RT   bisphosphate 3'-nucleotidase inhibited by inositol 1,4-bisphosphate.";
RL   J. Biol. Chem. 274:13619-13628(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=B-cell;
RA   Yenush L., Gil-Mascarell M., Serrano R., Rodriguez P.L.;
RT   "Hydrolysis of inositol-1,4-bisphosphate by human and yeast lithium
RT   sensitive 3'-phosphoadenosine 5'-phosphate nucleotidases.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 6-308 IN COMPLEX WITH
RP   MAGNESIUM IONS AND AMP.
RG   Structural genomics consortium (SGC);
RT   "Human 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1) in complex with
RT   AMP, PO4 and magnesium.";
RL   Submitted (APR-2009) to the PDB data bank.
CC   -!- FUNCTION: Converts adenosine 3'-phosphate 5'-phosphosulfate (PAPS)
CC       to adenosine 5'-phosphosulfate (APS) and 3'(2')-phosphoadenosine
CC       5'- phosphate (PAP) to AMP. Has 1000-fold lower activity towards
CC       inositol 1,4-bisphosphate (Ins(1,4)P2) and inositol 1,3,4-
CC       trisphosphate (Ins(1,3,4)P3), but does not hydrolyze Ins(1)P,
CC       Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6.
CC       {ECO:0000269|PubMed:10224133}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-bisphosphate + H(2)O =
CC       adenosine 5'-phosphate + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Uncompetitive inhibition by micromolar
CC       concentrations of lithium. Competitive inhibition by inositol 1,4-
CC       bisphosphate. {ECO:0000269|PubMed:10224133}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95861-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95861-2; Sequence=VSP_009937;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O95861-3; Sequence=VSP_054807;
CC       Name=4;
CC         IsoId=O95861-4; Sequence=VSP_054808;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, liver, pancreas
CC       and heart. Detected at lower levels in brain, placenta, lung and
CC       skeletal muscle. {ECO:0000269|PubMed:10224133}.
CC   -!- SIMILARITY: Belongs to the inositol monophosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF125042; AAD17329.1; -; mRNA.
DR   EMBL; AJ249339; CAB65115.1; -; mRNA.
DR   EMBL; AK291943; BAF84632.1; -; mRNA.
DR   EMBL; AK298476; BAG60687.1; -; mRNA.
DR   EMBL; AK300777; BAG62441.1; -; mRNA.
DR   EMBL; AC103590; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471100; EAW93306.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93308.1; -; Genomic_DNA.
DR   EMBL; BC017801; AAH17801.1; -; mRNA.
DR   CCDS; CCDS41469.1; -. [O95861-1]
DR   CCDS; CCDS65787.1; -. [O95861-3]
DR   CCDS; CCDS65788.1; -. [O95861-4]
DR   RefSeq; NP_001273078.1; NM_001286149.1. [O95861-3]
DR   RefSeq; NP_001273079.1; NM_001286150.1. [O95861-4]
DR   RefSeq; NP_001273080.1; NM_001286151.1. [O95861-3]
DR   RefSeq; NP_006076.4; NM_006085.5. [O95861-1]
DR   RefSeq; XP_005273057.1; XM_005273000.3. [O95861-1]
DR   UniGene; Hs.406134; -.
DR   PDB; 2WEF; X-ray; 1.80 A; A=6-308.
DR   PDBsum; 2WEF; -.
DR   ProteinModelPortal; O95861; -.
DR   SMR; O95861; 6-308.
DR   BioGrid; 115653; 1.
DR   IntAct; O95861; 1.
DR   MINT; MINT-5002343; -.
DR   STRING; 9606.ENSP00000318852; -.
DR   DEPOD; O95861; -.
DR   PhosphoSite; O95861; -.
DR   REPRODUCTION-2DPAGE; IPI00410214; -.
DR   PaxDb; O95861; -.
DR   PRIDE; O95861; -.
DR   Ensembl; ENST00000322067; ENSP00000318852; ENSG00000162813.
DR   Ensembl; ENST00000414869; ENSP00000410348; ENSG00000162813. [O95861-4]
DR   Ensembl; ENST00000469520; ENSP00000446828; ENSG00000162813.
DR   Ensembl; ENST00000544404; ENSP00000444398; ENSG00000162813. [O95861-3]
DR   GeneID; 10380; -.
DR   KEGG; hsa:10380; -.
DR   UCSC; uc001hma.3; human. [O95861-1]
DR   UCSC; uc010puh.2; human.
DR   CTD; 10380; -.
DR   GeneCards; GC01M220230; -.
DR   H-InvDB; HIX0001601; -.
DR   HGNC; HGNC:1096; BPNT1.
DR   HPA; HPA048461; -.
DR   MIM; 604053; gene.
DR   neXtProt; NX_O95861; -.
DR   PharmGKB; PA25407; -.
DR   eggNOG; COG0483; -.
DR   GeneTree; ENSGT00530000063462; -.
DR   HOGENOM; HOG000293205; -.
DR   HOVERGEN; HBG050719; -.
DR   KO; K01082; -.
DR   OMA; INQPFYN; -.
DR   OrthoDB; EOG7WQ7SQ; -.
DR   PhylomeDB; O95861; -.
DR   TreeFam; TF314300; -.
DR   BRENDA; 3.1.3.7; 2681.
DR   Reactome; REACT_6913; Cytosolic sulfonation of small molecules.
DR   EvolutionaryTrace; O95861; -.
DR   GenomeRNAi; 10380; -.
DR   NextBio; 35473949; -.
DR   PRO; PR:O95861; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; O95861; -.
DR   CleanEx; HS_BPNT1; -.
DR   ExpressionAtlas; O95861; baseline and differential.
DR   Genevisible; O95861; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0008441; F:3'(2'),5'-bisphosphate nucleotidase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome.
DR   GO; GO:0016311; P:dephosphorylation; TAS:GOC.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR020583; Inositol_monoP_metal-BS.
DR   InterPro; IPR000760; Inositol_monophosphatase.
DR   InterPro; IPR020550; Inositol_monophosphatase_CS.
DR   PANTHER; PTHR20854; PTHR20854; 1.
DR   Pfam; PF00459; Inositol_P; 1.
DR   PROSITE; PS00629; IMP_1; 1.
DR   PROSITE; PS00630; IMP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Hydrolase; Lithium; Magnesium; Metal-binding; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895,
FT                                ECO:0000269|PubMed:22814378}.
FT   CHAIN         2    308       3'(2'),5'-bisphosphate nucleotidase 1.
FT                                /FTId=PRO_0000142527.
FT   REGION      119    122       Substrate binding.
FT   REGION      195    198       Substrate binding.
FT   METAL        74     74       Magnesium 1.
FT   METAL       117    117       Magnesium 1.
FT   METAL       117    117       Magnesium 2.
FT   METAL       119    119       Magnesium 1; via carbonyl oxygen.
FT   METAL       120    120       Magnesium 2.
FT   METAL       247    247       Magnesium 2.
FT   BINDING      74     74       Substrate. {ECO:0000250}.
FT   BINDING     247    247       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:19413330,
FT                                ECO:0000269|PubMed:22223895,
FT                                ECO:0000269|PubMed:22814378}.
FT   MOD_RES     122    122       Phosphothreonine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES     244    244       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9Z0S1}.
FT   VAR_SEQ       1     55       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054807.
FT   VAR_SEQ      76    111       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054808.
FT   VAR_SEQ     277    308       KHMNSAGVLATLRNYDYYASRVPESIKNALVP -> SHRTW
FT                                PKPDFFRAQFFLESHSCFSRNFKNVSTPIKNIYDVIIYAYE
FT                                TDL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009937.
FT   CONFLICT    221    221       A -> V (in Ref. 6; AAH17801).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       G -> S (in Ref. 2; CAB65115).
FT                                {ECO:0000305}.
FT   HELIX         7     32       {ECO:0000244|PDB:2WEF}.
FT   STRAND       38     42       {ECO:0000244|PDB:2WEF}.
FT   STRAND       45     47       {ECO:0000244|PDB:2WEF}.
FT   HELIX        49     65       {ECO:0000244|PDB:2WEF}.
FT   STRAND       70     75       {ECO:0000244|PDB:2WEF}.
FT   HELIX        84     86       {ECO:0000244|PDB:2WEF}.
FT   HELIX        93     96       {ECO:0000244|PDB:2WEF}.
FT   HELIX       102    104       {ECO:0000244|PDB:2WEF}.
FT   HELIX       109    111       {ECO:0000244|PDB:2WEF}.
FT   STRAND      112    120       {ECO:0000244|PDB:2WEF}.
FT   HELIX       122    126       {ECO:0000244|PDB:2WEF}.
FT   HELIX       130    132       {ECO:0000244|PDB:2WEF}.
FT   STRAND      134    141       {ECO:0000244|PDB:2WEF}.
FT   STRAND      144    152       {ECO:0000244|PDB:2WEF}.
FT   TURN        153    158       {ECO:0000244|PDB:2WEF}.
FT   STRAND      167    172       {ECO:0000244|PDB:2WEF}.
FT   TURN        173    175       {ECO:0000244|PDB:2WEF}.
FT   STRAND      176    180       {ECO:0000244|PDB:2WEF}.
FT   STRAND      191    194       {ECO:0000244|PDB:2WEF}.
FT   STRAND      196    198       {ECO:0000244|PDB:2WEF}.
FT   HELIX       201    208       {ECO:0000244|PDB:2WEF}.
FT   STRAND      213    217       {ECO:0000244|PDB:2WEF}.
FT   HELIX       221    229       {ECO:0000244|PDB:2WEF}.
FT   STRAND      234    238       {ECO:0000244|PDB:2WEF}.
FT   HELIX       245    257       {ECO:0000244|PDB:2WEF}.
FT   STRAND      261    263       {ECO:0000244|PDB:2WEF}.
FT   STRAND      284    289       {ECO:0000244|PDB:2WEF}.
FT   HELIX       291    295       {ECO:0000244|PDB:2WEF}.
FT   HELIX       300    305       {ECO:0000244|PDB:2WEF}.
SQ   SEQUENCE   308 AA;  33392 MW;  A5952F5E31C8CFCB CRC64;
     MASSNTVLMR LVASAYSIAQ KAGMIVRRVI AEGDLGIVEK TCATDLQTKA DRLAQMSICS
     SLARKFPKLT IIGEEDLPSE EVDQELIEDS QWEEILKQPC PSQYSAIKEE DLVVWVDPLD
     GTKEYTEGLL DNVTVLIGIA YEGKAIAGVI NQPYYNYEAG PDAVLGRTIW GVLGLGAFGF
     QLKEVPAGKH IITTTRSHSN KLVTDCVAAM NPDAVLRVGG AGNKIIQLIE GKASAYVFAS
     PGCKKWDTCA PEVILHAVGG KLTDIHGNVL QYHKDVKHMN SAGVLATLRN YDYYASRVPE
     SIKNALVP
//
